# Commission Directive 2013/41/EUShow full title

Commission Directive 2013/41/EU of 18 July 2013 amending Directive 98/8/EC of the European Parliament and of the Council to            include 1R-trans phenothrin as an active substance in Annex I thereto (Text with EEA relevance)         

        - Previous
        - Next

U.K.

# Commission Directive 2013/41/EU                     

# of 18 July 2013

# amending Directive 98/8/EC of the European Parliament and of the Council to include 1R-trans phenothrin as an active substance                        in Annex I thereto                     

# (Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing                           of biocidal products on the market(1), and in particular the second subparagraph of Article 16(2) thereof,                        

Whereas:

(1)Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in                              Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products                              on the market(2) establishes a list of active substances to be assessed, with a view to their possible inclusion in Annex I, IA or IB to Directive                              98/8/EC. That list includes d-phenothrin.

(2)Pursuant to Regulation (EC) No 1451/2007, d-phenothrin has been evaluated in accordance with Article 11(2) of Directive 98/8/EC                              for use in product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to that                              Directive.

(3)The data submitted for the purpse of the evaluation allowed conclusions to be drawn only regarding a certain form of d-phenothrin,                              i.e. a substance containing at least 89 % w/w of 1R-trans phenothrin. In accordance with current practice for naming of substances(3), that substance should be considered as mono-constituent and named 1R-trans phenothrin. The evaluation did not allow conclusions                              to be drawn regarding any other substance complying with the definition of d-phenothrin in the abovementioned list of active                              substances in Regulation (EC) No 1451/2007. Therefore, only 1R-trans phenothrin should be included in Annex I to Directive                              98/8/EC based on the existing evaluation.

(4)Ireland was designated as rapporteur Member State and submitted the competent authority report, together with a recommendation,                              to the Commission on 29 July 2010 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.

(5)The competent authority report was reviewed by the Member States and the Commission. In accordance with Article 15(4) of Regulation                              (EC) No 1451/2007, the findings of the review were incorporated, within the Standing Committee on Biocidal Products on 1 March                              2013, in an assessment report.

(6)It appears from the evaluations that biocidal products used as insecticides, acaricides and products to control other arthropods                              and containing 1R-trans phenothrin may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.                              It is therefore appropriate to include 1R-trans phenothrin for use in product-type 18 in Annex I to that Directive.

(7)Not all potential uses and exposure scenarios have been evaluated at Union level. It is therefore appropriate to require that                              Member States assess those uses or exposure scenarios and those risks to human populations and to environmental compartments                              that have not been representatively addressed in the Union level risk assessment and, when granting product authorisations,                              ensure that appropriate measures are taken or specific conditions imposed in order to reduce the identified risks to acceptable                              levels.

(8)In view of the risks identified for human health, it is appropriate to require that safe operational procedures are established                              for ultra low volume (ULV) application, and that products are used with appropriate personal protective equipment, unless                              it can be demonstrated in the application for product authorisation that risks can be reduced to an acceptable level by other                              means.

(9)In view of the risks identified for the environment, it is appropriate to require that product authorisations are subject                              to appropriate risk mitigation measures for the protection of honey bees.

(10)For products containing 1R-trans phenothrin that may lead to residues in food or feed, Member States should verify the need                              to set new or to amend existing maximum residue levels (MRLs) according to Regulation (EC) No 470/2009 of the European Parliament                              and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically                              active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC                              of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council(4) or Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels                              of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC(5), and take any appropriate risk mitigation measures ensuring that the applicable MRLs are not exceeded.

(11)The provisions of this Directive should be applied simultaneously in all Member States in order to ensure equal treatment                              on the Union market of biocidal products of product-type 18 containing the active substance 1R-trans phenothrin and also to                              facilitate the proper operation of the biocidal products market in general.

(12)A reasonable period should be allowed to elapse before an active substance is included in Annex I to Directive 98/8/EC, in                              order to permit Member States and interested parties to prepare themselves to meet the new requirements entailed and to ensure                              that applicants who have prepared dossiers can benefit fully from the 10-year period of data protection, which, in accordance                              with Article 12(1)(c)(ii) of Directive 98/8/EC, starts from the date of inclusion.

(13)After inclusion, Member States should be allowed a reasonable period to implement Article 16(3) of Directive 98/8/EC.

(14)Directive 98/8/EC should therefore be amended accordingly.

(15)In accordance with the Joint Political Declaration of Member States and the Commission of 28 September 2011 on explanatory                              documents(6), Member States have undertaken to accompany, in justified cases, the notification of their transposition measures with one                              or more documents explaining the relationship between the components of a directive and the corresponding parts of national                              transposition instruments.

(16)The measures provided for in this Directive are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS DIRECTIVE:

# Article 1U.K.

Annex I to Directive 98/8/EC is amended in accordance with the Annex to this Directive.

# Article 2U.K.

1.Member States shall adopt and publish, by 31 August 2014 at the latest, the laws, regulations and administrative provisions                        necessary to comply with this Directive. They shall forthwith communicate to the Commission the text of those provisions.                  

They shall apply those provisions from 1 September 2015.

When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference                     on the occasion of their official publication. Member States shall determine how such reference is to be made.                  

2.Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the                        field covered by this Directive.                  

# Article 3U.K.

This Directive shall enter into force on the twentieth day following that of its publication in the *Official Journal of the European Union*.                  

# Article 4U.K.

This Directive is addressed to the Member States.

Done at Brussels, 18 July 2013.

*For the Commission*                            

*The President*                            

José Manuel Barroso                            

## ANNEXU.K.

In Annex I to Directive 98/8/EC, the following entry is added:

1

OJ L 123, 24.4.1998, p. 1.                           

2

OJ L 325, 11.12.2007, p. 3.                           

3

See in particular *Guidance for identification and naming of substances under REACH and CLP*, ECHA-11-G-10.1-EN, p. 19 f.                           

4

OJ L 152, 16.6.2009, p. 11.                           

5

OJ L 70, 16.3.2005, p. 1.                           

6

OJ C 369, 17.12.2011, p. 14.